Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Modine Manufacturing
MOD
$9.46B
| $897K | ﹤0.01% |
73,500
-273,900
| -79% | -$3.41M |
|
|
TNH
2577
DELISTED
Terra Nitrogen
TNH
| $894K | ﹤0.01% |
9,100
-31,002
| -77% | -$3.18M |
|
2578
Scully Royalty
SRL
$75.4M
| $892K | ﹤0.01% |
100,203
-4,940
| -5% | -$49.7K |
|
|
BKEP
2579
DELISTED
Blueknight Energy Partners L.P.
BKEP
| $892K | ﹤0.01% |
132,094
+24,655
| +23% | +$173K |
|
2580
Madrigal Pharmaceuticals
MDGL
$12.6B
| $891K | ﹤0.01% |
57,875
+400
| +0.7% | +$6.29K |
|
2581
Global Partners
GLP
$1.65B
| $889K | ﹤0.01% |
45,609
-76,038
| -63% | -$1.51M |
|
|
IRS
2582
IRSA Inversiones y Representaciones
IRS
$1.31B
| $889K | ﹤0.01% |
37,668
-8,260
| -18% | -$177K |
|
|
LOAN
2583
Manhattan Bridge Capital
LOAN
$48M
| $889K | ﹤0.01% |
150,700
+21,200
| +16% | +$137K |
|
|
TULP
2584
Bloomia Holdings
TULP
$16.1M
| $885K | ﹤0.01% |
84,843
+229
| +0.3% | +$2.49K |
|
2585
Hennessy Advisors
HNNA
$77.4M
| $882K | ﹤0.01% |
52,450
-1,700
| -3% | -$31.3K |
|
|
MGP
2586
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $877K | ﹤0.01% |
+32,415
| New | +$831K |
|
|
GLUU
2587
DELISTED
Glu Mobile Inc.
GLUU
| $877K | ﹤0.01% |
+386,200
| New | +$834K |
|
|
GZT
2588
DELISTED
Gazit-globe Ltd
GZT
| $877K | ﹤0.01% |
83,800
+10,500
| +14% | +$104K |
|
2589
Oppenheimer Holdings
OPY
$1.18B
| $874K | ﹤0.01% |
51,136
-56,364
| -52% | -$974K |
|
|
RPRX
2590
DELISTED
Repros Therapeutics Inc.
RPRX
| $873K | ﹤0.01% |
727,113
+10,700
| +1% | +$13.4K |
|
|
MTLS
2591
Materialise
MTLS
$366M
| $869K | ﹤0.01% |
95,500
+23,200
| +32% | +$197K |
|
2592
Silicon Laboratories
SLAB
$7.14B
| $868K | ﹤0.01% |
11,798
-17,302
| -59% | -$1.21M |
|
2593
Xenon Pharmaceuticals
XENE
$6.1B
| $868K | ﹤0.01% |
217,090
+102,890
| +90% | +$809K |
|
|
AIFU
2594
AIFU Inc
AIFU
$193M
| $868K | ﹤0.01% |
251
+32
| +15% | +$112K |
|
|
QTS
2595
DELISTED
QTS REALTY TRUST, INC.
QTS
| $868K | ﹤0.01% |
+17,800
| New | +$893K |
|
|
PBT
2596
Permian Basin Royalty Trust
PBT
$1.36B
| $864K | ﹤0.01% |
92,427
-124,491
| -57% | -$1.11M |
|
|
USAP
2597
DELISTED
Universal Stainless & Alloy
USAP
| $862K | ﹤0.01% |
50,700
+1,900
| +4% | +$28.8K |
|
2598
TIM SA
TIMB
$9.1B
| $855K | ﹤0.01% |
53,500
-28,500
| -35% | -$427K |
|
|
MRTX
2599
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $854K | ﹤0.01% |
+164,302
| New | +$900K |
|
2600
Virco
VIRC
$94.8M
| $852K | ﹤0.01% |
215,600
-10,700
| -5% | -$44.6K |
|
Similar funds
Renaissance Technologies's Q1 2017 Portfolio in Review
As of Q1 2017, Renaissance Technologies held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Renaissance Technologies's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Renaissance Technologies added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Renaissance Technologies's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Renaissance Technologies fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Renaissance Technologies opened 433 new positions and closed 462 in Q1 2017.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.